Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.7800
+0.0161 (2.11%)
At close: Mar 26, 2026
Cell Source Market Cap
Cell Source has a market cap or net worth of $37.29 million as of March 26, 2026. Its market cap has increased by 48.10% in one year.
Market Cap
37.29M
Enterprise Value
47.37M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.78
Market Cap Chart
Since July 1, 2014, Cell Source's market cap has increased from 36.03M to 37.29M, an increase of 3.51%. That is a compound annual growth rate of 0.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 37.29M | 52.78% |
| Dec 31, 2025 | 24.41M | 59.96% |
| Dec 31, 2024 | 15.26M | -14.98% |
| Dec 27, 2023 | 17.95M | -40.09% |
| Dec 29, 2022 | 29.96M | -30.67% |
| Dec 31, 2021 | 43.22M | -32.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuo Therapeutics | 60.36M |
| Vicapsys Life Sciences | 48.56M |
| Anebulo Pharmaceuticals | 41.60M |
| ZIVO Bioscience | 33.01M |
| Harvard Apparatus Regenerative Technology | 29.49M |
| Arch Biopartners | 27.04M |
| Provectus Biopharmaceuticals | 21.41M |
| NKGen Biotech | 20.90M |